Sherman S E, Stoutenburg E, Long D L, Juraschek S P, Cushman M, Howard V J, Tracy R P, Judd S E, Kamin Mukaz D, Zakai N A, Plante T B
Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
University of Vermont Larner College of Medicine, Burlington, VT, USA.
J Hum Hypertens. 2024 Dec;38(12):836-843. doi: 10.1038/s41371-024-00963-w. Epub 2024 Oct 1.
Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration. As such, leptin may mediate some of the excess burden of incident hypertension among Black adults. REGARDS enrolled 30,239 adults aged ≥45 years from 48 US states in 2003-07. Baseline leptin was measured in a sex- and race-stratified sample of 4400 participants. Modified Poisson regression estimated relative risk (RR) of incident hypertension (new ≥140/≥90 mmHg threshold or use of antihypertensives) per SD of log-transformed leptin, stratified by obesity (BMI of 30 kg/m). Inverse odds ratio weighting estimated the % mediation by leptin of the excess hypertension RR among Black relative to White participants. Among the 1821 participants without prevalent hypertension, 35% developed incident hypertension. Obesity modified the relationship between leptin and incident hypertension (P-interaction 0.006) such that higher leptin was associated with greater hypertension risk in the crude model among those with BMI < 30 kg/m, but not those with BMI ≥ 30 kg/m. This was fully attenuated when adjusting for anthropometric measures. In the crude model, Black adults had a 52% greater risk of incident hypertension. Leptin did not significantly mediate this disparity. In this national U.S. sample, leptin was associated with incident hypertension among non-obese but not obese adults. Future investigations should focus on the effect of weight modification on incident hypertension among non-obese adults with elevated leptin.
瘦素是一种脂肪因子,在动物模型中与肥胖和高血压相关。瘦素是否独立于肥胖与高血压相关尚不清楚。与白人成年人相比,黑人成年人循环中的瘦素浓度更高。因此,瘦素可能介导了黑人成年人中部分新增高血压的额外负担。REGARDS研究在2003年至2007年期间从美国48个州招募了30239名年龄≥45岁的成年人。在4400名参与者的按性别和种族分层的样本中测量了基线瘦素水平。采用修正泊松回归按肥胖程度(体重指数为30kg/m²)分层,估计每标准差对数转换后的瘦素水平下新增高血压(新的血压阈值≥140/≥90mmHg或使用抗高血压药物)的相对风险(RR)。逆概率比加权法估计了相对于白人参与者,瘦素对黑人中高血压RR过高的介导百分比。在1821名无高血压病史的参与者中,35%出现了新增高血压。肥胖改变了瘦素与新增高血压之间的关系(P交互作用=0.006),在体重指数<30kg/m²的人群中,在粗模型中较高的瘦素与更高的高血压风险相关,但在体重指数≥30kg/m²的人群中并非如此。在调整人体测量指标后,这种相关性完全减弱。在粗模型中,黑人成年人新增高血压的风险高52%。瘦素并未显著介导这种差异。在这个美国全国性样本中,瘦素与非肥胖成年人的新增高血压相关,但与肥胖成年人无关。未来的研究应关注体重改变对瘦素水平升高的非肥胖成年人中新增高血压的影响。